What's Happening?
The Pancreatic Cancer Action Network (PanCAN) is actively funding grants for basic, translational, and clinical research to accelerate advancements in understanding, preventing, detecting, treating, and curing pancreatic cancer. These grants are offered
to scientists and clinicians at various career levels. PanCAN's Scientific and Medical Affairs team conducts independent and collaborative research as part of its strategic approach to increase survival rates for pancreatic cancer patients. A key component of PanCAN's strategy is its Public Access Publication Policy, which mandates that researchers receiving their grants publish their findings in peer-reviewed journals. To ensure broad accessibility, these published manuscripts are then made publicly available through the National Institutes of Health's PubMed Central (PMC). PanCAN also advocates for the use of the free Open Science Framework (OSF) to enhance transparency, foster collaboration, and increase the visibility of research.
Why It's Important?
PanCAN's commitment to funding diverse research initiatives is crucial for a disease like pancreatic cancer, which often has a low survival rate and limited treatment options. By supporting research across basic, translational, and clinical stages, PanCAN helps bridge the gap between scientific discovery and patient care. The organization's Public Access Publication Policy is particularly significant as it ensures that new knowledge generated from funded research is not confined to academic circles but is readily available to the broader scientific community and the public. This transparency and accessibility can accelerate further research, facilitate new collaborations, and ultimately lead to faster development of improved prevention, detection, and treatment strategies. This approach benefits not only researchers but also patients and their families by providing access to the latest findings and fostering a more informed and collaborative research environment.
What's Next?
PanCAN will continue to offer grants for pancreatic cancer research, with ongoing calls for proposals to scientists and clinicians. The organization will also maintain its rigorous evaluation of its research grants program to assess its effectiveness in building a comprehensive research community and moving science toward a cure. Researchers funded by PanCAN will be expected to adhere to the Public Access Publication Policy, ensuring their findings are published in peer-reviewed journals and made available on PubMed Central. PanCAN will also likely continue to promote the use of the Open Science Framework to enhance research transparency and collaboration. These efforts aim to continuously generate new knowledge, foster a collaborative research environment, and ultimately improve outcomes for individuals affected by pancreatic cancer.
Beyond the Headlines
PanCAN's emphasis on public access to research findings has broader implications for scientific integrity and public trust in medical research. By requiring grantees to make their work publicly available, PanCAN champions open science principles, which can combat issues like publication bias and ensure that all relevant data contributes to the collective scientific understanding. This transparency can also empower patients and advocates to stay informed about the latest developments, fostering a more engaged and knowledgeable patient community. Furthermore, by making research accessible, PanCAN helps democratize scientific knowledge, potentially inspiring new researchers and innovators from diverse backgrounds to contribute to the field. This model of open access in medical research could set a precedent for other disease advocacy organizations, accelerating progress across various health challenges.
